Capital International Sarl’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.5M | Buy |
223,389
+37,218
| +20% | +$16.6M | 1.91% | 9 |
|
|
2025
Q1 | $90.3M | Buy |
186,171
+17,579
| +10% | +$8.52M | 2.04% | 9 |
|
|
2024
Q4 | $67.9M | Buy |
168,592
+25,544
| +18% | +$10.3M | 1.57% | 12 |
|
|
2024
Q3 | $66.5M | Buy |
143,048
+18,968
| +15% | +$8.82M | 1.71% | 9 |
|
|
2024
Q2 | $58.2M | Buy |
124,080
+7,602
| +7% | +$3.56M | 1.78% | 10 |
|
|
2024
Q1 | $48.7M | Buy |
116,478
+22,891
| +24% | +$9.57M | 1.61% | 9 |
|
|
2023
Q4 | $38.1M | Buy |
93,587
+14,113
| +18% | +$5.74M | 1.43% | 10 |
|
|
2023
Q3 | $27.6M | Buy |
79,474
+5,799
| +8% | +$2.02M | 1.26% | 17 |
|
|
2023
Q2 | $25.9M | Buy |
73,675
+15,253
| +26% | +$5.37M | 1.16% | 16 |
|
|
2023
Q1 | $18.4M | Buy |
58,422
+7,652
| +15% | +$2.41M | 0.93% | 28 |
|
|
2022
Q4 | $14.7M | Buy |
50,770
+3,057
| +6% | +$883K | 1.03% | 22 |
|
|
2022
Q3 | $13.8M | Buy |
47,713
+4,461
| +10% | +$1.29M | 1.12% | 16 |
|
|
2022
Q2 | $12.2M | Buy |
43,252
+1,225
| +3% | +$345K | 0.98% | 17 |
|
|
2022
Q1 | $11M | Sell |
42,027
-4,528
| -10% | -$1.18M | 0.54% | 53 |
|
|
2021
Q4 | $10.2M | Buy |
46,555
+33,939
| +269% | +$7.45M | 0.49% | 60 |
|
|
2021
Q3 | $2.29M | Sell |
12,616
-2,214
| -15% | -$402K | 0.2% | 123 |
|
|
2021
Q2 | $2.99M | Buy |
14,830
+341
| +2% | +$68.8K | 0.26% | 106 |
|
|
2021
Q1 | $3.11M | Buy |
14,489
+374
| +3% | +$80.4K | 0.3% | 93 |
|
|
2020
Q4 | $3.34M | Buy |
14,115
+393
| +3% | +$92.9K | 0.35% | 87 |
|
|
2020
Q3 | $3.73M | Buy |
13,722
+536
| +4% | +$146K | 0.46% | 70 |
|
|
2020
Q2 | $3.83M | Buy |
13,186
+2,424
| +23% | +$704K | 0.51% | 59 |
|
|
2020
Q1 | $2.56M | Buy |
10,762
+3,188
| +42% | +$759K | 0.47% | 64 |
|
|
2019
Q4 | $1.66M | Buy |
+7,574
| New | +$1.66M | 0.26% | 104 |
|